ClariTrial | Search Clinical Trials

Explore/Breast Cancer

Status

Phase

18,991 results for “Breast Cancer”

Page 1 of 1267

Withdrawn

Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

Early Phase 1Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8

AtezolizumabCryosurgeryNab-paclitaxel

Mayo Clinic0Completes Nov 2021

Compare CT.gov Full analysis →

Completed

Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer

Phase 2Metastatic Breast Cancer

TKI258

Novartis Pharmaceuticals43 participants38 sites · United States, Canada, FinlandCompletes Mar 2011

Compare CT.gov Full analysis →

UNKNOWN

Construction and Effect Evaluation of Malignant Fungating Wounds Care Regimen for Breast Cancer Patients

N/AMalignant Fungating Wound

malignant fungating wounds care regimen

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University50 participants1 site · ChinaCompletes Jun 2024

Compare CT.gov Full analysis →

UNKNOWN

Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema

N/ABreast CancerPhysical ActivityLymphedema of Upper Arm

Resistance Training

Pontificia Universidad Catolica de Chile106 participants1 site · ChileCompletes Dec 2022

Compare CT.gov Full analysis →

Completed

Investigating Public Enthusiasm for Mammography Screening in Denmark

N/ABreast Neoplasm FemaleMammography ScreeningDecision Making

Information about hypothetical mammography screening without benefits

University of Aarhus768 participants1 site · DenmarkCompletes Jan 2021

Compare CT.gov Full analysis →

Recruiting

Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies

N/ABreast Neoplasm Female

Preparation in Self-Hypnosis by anchoringConversational HypnosisPreparation in Self-Hypnosis by anchoring + Conversational Hypnosis

Hospital St. Joseph, Marseille, France100 participants1 site · FranceCompletes Dec 2024

Compare CT.gov Full analysis →

Terminated

Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer

Phase 2Breast Cancer

BevacizumabPaclitaxel

Hellenic Oncology Research Group46 participants11 sites · GreeceCompletes Jan 2017

Compare CT.gov Full analysis →

UNKNOWN

Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

N/Abrca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer

DNA analysismutation analysispolymorphism analysis+2 more

Gynecologic Oncology Group10,000 participants1 site · United StatesCompletes Dec 2009

Compare CT.gov Full analysis →

Not Yet Recruiting

Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol

N/ABreast Cancer

Eastern Cooperative Oncology Group600 participantsCompletes Apr 2027

Compare CT.gov Full analysis →

UNKNOWN

Evaluation for the Effectiveness and Safety of Cryo-ablation in the Treatment of Early Invasive Breast Cancer

N/ABreast Cancer

cryo-ablation

Fudan University186 participants1 site · ChinaCompletes May 2025

Compare CT.gov Full analysis →

Completed

Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer

N/ABreast Cancer Female

Breast Cancer Locator (BCL) guided partial mastectomyWire Localized (WL) partial mastectomy

CairnSurgical, Inc.480 participants23 sites · United States, Austria, CanadaCompletes Dec 2025

Compare CT.gov Full analysis →

By Invitation

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

N/ABreast Carcinoma

Electronic Health Record ReviewInterviewMedia Intervention+2 more

OHSU Knight Cancer Institute1,141 participants1 site · United StatesCompletes Apr 2025

Compare CT.gov Full analysis →

Withdrawn

A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer

Phase 2Breast CancerTriple Negative Breast NeoplasmsTriple-Negative Breast Neoplasm

BavituximabTaxane

Peregrine Pharmaceuticals0Completes Apr 2017

Compare CT.gov Full analysis →

Recruiting

Application of Radiomics in Breast Cancer

N/ABreast CancerUltrasoundElastography

Endocrine therapy

Second Affiliated Hospital, School of Medicine, Zhejiang University2,000 participants1 site · ChinaCompletes Dec 2023

Compare CT.gov Full analysis →

Completed

A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer

Phase 3Breast Cancer

gemcitabine/carboplatinIniparib

Sanofi519 participants102 sites · United StatesCompletes Jan 2011

Compare CT.gov Full analysis →

1–15 of 18,991

Explore/Breast Cancer

Status

Phase

18,991 results for “Breast Cancer”

Page 1 of 1267

Withdrawn

Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

Early Phase 1Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8

AtezolizumabCryosurgeryNab-paclitaxel

Mayo Clinic0Completes Nov 2021

Compare CT.gov Full analysis →

Completed

Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer

Phase 2Metastatic Breast Cancer

TKI258

Novartis Pharmaceuticals43 participants38 sites · United States, Canada, FinlandCompletes Mar 2011

Compare CT.gov Full analysis →

UNKNOWN

Construction and Effect Evaluation of Malignant Fungating Wounds Care Regimen for Breast Cancer Patients

N/AMalignant Fungating Wound

malignant fungating wounds care regimen

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University50 participants1 site · ChinaCompletes Jun 2024

Compare CT.gov Full analysis →

UNKNOWN

Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema

N/ABreast CancerPhysical ActivityLymphedema of Upper Arm

Resistance Training

Pontificia Universidad Catolica de Chile106 participants1 site · ChileCompletes Dec 2022

Compare CT.gov Full analysis →

Completed

Investigating Public Enthusiasm for Mammography Screening in Denmark

N/ABreast Neoplasm FemaleMammography ScreeningDecision Making

Information about hypothetical mammography screening without benefits

University of Aarhus768 participants1 site · DenmarkCompletes Jan 2021

Compare CT.gov Full analysis →

Recruiting

Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies

N/ABreast Neoplasm Female

Preparation in Self-Hypnosis by anchoringConversational HypnosisPreparation in Self-Hypnosis by anchoring + Conversational Hypnosis

Hospital St. Joseph, Marseille, France100 participants1 site · FranceCompletes Dec 2024

Compare CT.gov Full analysis →

Terminated

Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer

Phase 2Breast Cancer

BevacizumabPaclitaxel

Hellenic Oncology Research Group46 participants11 sites · GreeceCompletes Jan 2017

Compare CT.gov Full analysis →

UNKNOWN

Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers

N/Abrca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer

DNA analysismutation analysispolymorphism analysis+2 more

Gynecologic Oncology Group10,000 participants1 site · United StatesCompletes Dec 2009

Compare CT.gov Full analysis →

Not Yet Recruiting

Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol

N/ABreast Cancer

Eastern Cooperative Oncology Group600 participantsCompletes Apr 2027

Compare CT.gov Full analysis →

UNKNOWN

Evaluation for the Effectiveness and Safety of Cryo-ablation in the Treatment of Early Invasive Breast Cancer

N/ABreast Cancer

cryo-ablation

Fudan University186 participants1 site · ChinaCompletes May 2025

Compare CT.gov Full analysis →

Completed

Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer

N/ABreast Cancer Female

Breast Cancer Locator (BCL) guided partial mastectomyWire Localized (WL) partial mastectomy

CairnSurgical, Inc.480 participants23 sites · United States, Austria, CanadaCompletes Dec 2025

Compare CT.gov Full analysis →

By Invitation

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

N/ABreast Carcinoma

Electronic Health Record ReviewInterviewMedia Intervention+2 more

OHSU Knight Cancer Institute1,141 participants1 site · United StatesCompletes Apr 2025

Compare CT.gov Full analysis →

Withdrawn

A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer

Phase 2Breast CancerTriple Negative Breast NeoplasmsTriple-Negative Breast Neoplasm

BavituximabTaxane

Peregrine Pharmaceuticals0Completes Apr 2017

Compare CT.gov Full analysis →

Recruiting

Application of Radiomics in Breast Cancer

N/ABreast CancerUltrasoundElastography

Endocrine therapy

Second Affiliated Hospital, School of Medicine, Zhejiang University2,000 participants1 site · ChinaCompletes Dec 2023

Compare CT.gov Full analysis →

Completed

A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer

Phase 3Breast Cancer

gemcitabine/carboplatinIniparib

Sanofi519 participants102 sites · United StatesCompletes Jan 2011

Compare CT.gov Full analysis →

1–15 of 18,991